AdAlta Ltd (ASX:1AD) managing director Tim Oldham chats to Proactive’s Elisha Newell ahead of the Peak Asset Management Microcap Conference on Thursday, July 13. AdAlta is focused on developing a unique range of new drug treatments, and Oldham says the team is leveraging i-body technology to develop clinical solutions, primarily focused on fibrotic diseases. Investors can register to attend the Peak Asset Management conference in Melbourne here.
AdAlta talks i-body technology ahead of Peak Asset Management conference
